Price $0.70 |
Market Cap
126.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.54
|
P/S
6.22
|
Dividend %
-
|
|
P/CF
2.2
|
P/FCF
-
|
Op. Cash Flow
-47.6K
|
FCF
-1.0
|
|
Op. Margin
-502.30%
|
Net Margin
-506.00%
|
ROE
-121.10%
|
ROI
-
|
|
ROA
-43.90%
|
EPS Growth
-154.40%
|
Current Ratio
4.5
|
Debt/Equity
2.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $8.82 | - | - | 11.23B | Strong Buy |
| Invo Bioscience Inc (INVO) | $0.60 | - | - | 7.4M | Strong Buy |
| IM Cannabis Corp (IMCC) | $0.74 | - | - | 13.9M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.11 | - | - | 5.1M | Strong Buy |
| Shineco Inc (SISI) | $0.61 | - | - | 15.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
